Business
Futura Medical - Total Voting Rights
Futura Medical - Total Voting Rights.
About this update from Futura Medical Plc
[{"type":"text","content":"\n\n \n31 July 2023\n Futura Medical plc\n(\"Futura\" or the \"Company\")\nTotal Voting Rights\n \nFutura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, announces that for the purposes of the FCA's Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 300,712,293 Ordinary Shares.\n \nSince the Company currently holds no shares in treasury, the total number of voting rights in the Company is 300,712,293 and this figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.\n \nENDS\n \nFutura Medical plc\nJames Barder, Chief Executive Officer\nAngela Hildreth, Finance Director and COO\nEmail: [email protected]\nTel: +44 (0) 1483 685 670\nwww.futuramedical.com\n \nNominated Adviser and Sole Broker:\n \nLiberum\nPhil Walker/ Richard Lindley/ Ben Cryer\nTel: +44 (0) 20 3100 2000\n \nFor media enquiries please contact:\nOptimum Strategic Communications\nEva Haas/ Hollie Vile/ Jonathan Edwards/ Zoe Bolt\nEmail: [email protected]\nTel: +44 (0) 203 882 9621\n \n \n\n","length":3184,"tagName":"div"}]